20 exoskeleton startups show real commercial traction — half of them in medical rehab

Asked:

“Found list of successful startups about exoskeletons producing”

A scan dated 2 September 2026 surfaced 20 credible current or growth-stage exoskeleton producers with concrete traction — commercialization, funding, deployments, unit sales, regulatory clearance, or named enterprise customers: 10 medical / rehabilitation, 7 industrial / workplace, and 3 consumer / mobility. Bar length is the count of web-source mentions — a rough visibility signal, not market share.

Medical / rehabilitationIndustrial / workplaceConsumer / mobility

Wandercraft leads on both visibility and scale: a $75M Series D and deployments in 100+ facilities across four continents. nexi.fund

German Bionic names blue-chip customers outright — GXO, Canadian Tire, Currys, Nuremberg Airport and Charité Hospital Berlin. nasdaq.com

Consumer traction is real: Hypershell has sold hip-assist exoskeletons in 70+ countries and regions. en.people.cn

Warehouse suits scale in the field: Verve Motion is expanding an Ahold Delhaize pilot to 250+ suits, and HeroWear has logged 280,000+ deployed work hours. foodtradenews.com · humanoidroboticstechnology.com

Quieter names still show hard proof: Wearable Robotics (€5M Series A, 50+ units in 20 countries) and Fourier Intelligence (10+ years of commercial sales, $100M+ raised). jaredwatkins.com

Company	Segment	Product	HQ	Success evidence	Mentions	Source

Curated shortlist of 20 exoskeleton startups/growth companies with production evidence, one row per company, scan dated 2026-09-02. “Mentions” counts web-source mentions in the scan — a corroboration signal, not market share. Segment totals (10 medical, 7 industrial, 3 consumer) come from the precomputed aggregate set. Evidence quality varies by company; some headquarters and status cells are unresolved and shown as “—”. Mature corporations and failed or pivoted firms were excluded from the framing; all 20 shortlist rows are shown.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.